Class effects of angiotensin-converting enzyme inhibitors.

@article{Sica2000ClassEO,
  title={Class effects of angiotensin-converting enzyme inhibitors.},
  author={Domenic A. Sica},
  journal={The American journal of managed care},
  year={2000},
  volume={6 3 Suppl},
  pages={S85-108; quiz S109-11}
}
This review discusses important issues related to the use of angiotensin-converting enzyme inhibitors (ACEIs). ACEIs have been shown in clinical trials to slow progressive renal, cardiac, and vascular disease. The Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends ACEIs as alternative first… CONTINUE READING